Effect of Β-Hydroxy-Β-Methylbutyrate on Mirna Expression in Differentiating Equine Satellite Cells Exposed to Hydrogen Peroxide Karolina A

Total Page:16

File Type:pdf, Size:1020Kb

Effect of Β-Hydroxy-Β-Methylbutyrate on Mirna Expression in Differentiating Equine Satellite Cells Exposed to Hydrogen Peroxide Karolina A Chodkowska et al. Genes & Nutrition (2018) 13:10 https://doi.org/10.1186/s12263-018-0598-2 RESEARCH Open Access Effect of β-hydroxy-β-methylbutyrate on miRNA expression in differentiating equine satellite cells exposed to hydrogen peroxide Karolina A. Chodkowska, Anna Ciecierska, Kinga Majchrzak, Piotr Ostaszewski and Tomasz Sadkowski* Abstract Background: Skeletal muscle injury activates satellite cells to initiate processes of proliferation, differentiation, and hypertrophy in order to regenerate muscle fibers. The number of microRNAs and their target genes are engaged in satellite cell activation. β-Hydroxy-β-methylbutyrate (HMB) is known to prevent exercise-induced muscle damage. The purpose of this study was to evaluate the effect of HMB on miRNA and relevant target gene expression in differentiating equine satellite cells exposed to H2O2. We hypothesized that HMB may regulate satellite cell activity, proliferation, and differentiation, hence attenuate the pathological processes induced during an in vitro model of H2O2-related injury by changing the expression of miRNAs. Methods: Equine satellite cells (ESC) were isolated from the samples of skeletal muscle collected from young horses. ESC were treated with HMB (24 h) and then exposed to H2O2 (1 h). For the microRNA and gene expression assessment microarrays, technique was used. Identified miRNAs and genes were validated using real-time qPCR. Cell viability, oxidative stress, and cell damage were measured using colorimetric method and flow cytometry. Results: Analysis of miRNA and gene profile in differentiating ESC pre-incubated with HMB and then exposed to H2O2 revealed difference in the expression of 27 miRNAs and 4740 genes, of which 344 were potential target genes for identified miRNAs. Special attention was focused on differentially expressed miRNAs and their target genes involved in processes related to skeletal muscle injury. Western blot analysis showed protein protection in HMB-pre-treated group compared to control. The viability test confirmed that HMB enhanced cell survival after the hydrogen peroxide exposition. Conclusions: OurresultssuggestthatESCpre-incubatedwithHMBandexposedtoH2O2 could affect expression on miRNA levels responsible for skeletal muscle development, cell proliferation and differentiation, and activation of tissue repair after injury. Enrichment analyses for targeted genes revealed that a large group of genes was associated with the regulation of signaling pathways crucial for muscle tissue development, protein metabolism, muscle injury, and regeneration, as well as with oxidative stress response. Keywords: miRNA, HMB, Equine satellite cells, Muscle injury, Skeletal muscle * Correspondence: [email protected] Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences – SGGW, Nowoursynowska 159, 02-776 Warsaw, Poland © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Chodkowska et al. Genes & Nutrition (2018) 13:10 Page 2 of 20 Background also exposed to H2O2 an in vitro factor initiating cellular β-Hydroxy-β-methylbutyrate (HMB) is a metabolite of response similar to that observed in vivo during a short the essential amino acid leucine and is naturally synthe- intensive physical exercise and post-exercise injury. sized in animals, plants, and humans [1]. Dietary supple- mentation of HMB is used to enhance gains in strength Methods and lean body mass associated with resistance training Muscle samples and cell culture and for increasing lean mass in cancer-related cachexia Samples of skeletal muscles (m. semitendinosus)werecol- [2, 3]. Unlike anabolic hormones which only increase lected from 6 months old healthy stallions in a slaughter muscle protein synthesis to accelerate muscular hyper- house. Muscle samples (0.5 × 0.5 × 0.5 cm) were taken im- trophy, HMB increases dynamic strength [4, 5] and lean mediately, washed in phosphate-buffered saline (PBS) with body mass [6] acting as an anti-catabolic agent, reducing gradually decreasing antibiotic concentration [40.000 and protein breakdown [5] and cellular damage which may 20.000 IU Penicillium crystalicum (PC; Polfa, Poland) per accompany intense exercise [7]. Moreover, previous 100 ml PBS], cleaned from connective and fat tissue, cut studies have demonstrated that HMB supplementation and immediately suspended in sterile fetal bovine serum decreased plasma post-exercise creatine kinase and lactic (FBS; Life Technologies, USA) with 10% addition of acid in thoroughbreds [8]. dimethylsulfoxide (DMSO), gradually frozen to − 80 °C, and Reactive oxygen species (ROS), such a hydrogen per- finally stored in liquid nitrogen until use. oxide (H2O2), exert a critical regulatory role on skeletal muscle function [9, 10]. In resting muscle cells, free radi- Satellite cell isolation, proliferation, and differentiation cals and ROS are rapidly and efficiently neutralized by Equine satellite cells (ESC) were isolated according to antioxidants. Exercise creates an imbalance between the following protocol. Protease from Streptomyces gri- ROS and activates natural antioxidant mechanisms. seus (Pronase®, Sigma-Aldrich, USA) was reconstituted Moreover, ROS produced during exercise by inflamma- in low-glucose Dulbecco's modified Eagle’s medium tory cells may also be involved in delayed onset of (DMEM), GlutaMAX™, Pyruvate (Life Technologies, muscle damage observed during inflammation [11]. The USA), and stirred for 1 h, pH 7.3. The incubation buffer inflammatory response coincides with muscle repair, re- (IB) consisted per sample of Pronase 0.5 mg/ml, 18 ml generation, and growth, involving activation and prolif- of DMEM, FBS 2 ml (Life Technologies, USA), and PC eration of satellite cells followed by their terminal (20.000 IU). IB was filtered through a cellulose acetate differentiation. In response to the damage, quiescent sat- membrane syringe filter (Sigma-Aldrich, USA). The frag- ellite cells are activated and undergo several cycles of mented muscle tissue was thawed, washed in PBS with cell division prior to their withdrawal from the cell cycle PC (20.000 IU), and suspended in IB for 1.5 h at 37 °C, through terminal differentiation and finally fusion with shaken every 15 min. Then, samples were sieved through the damaged skeletal muscle fibers [12]. During training- cell strainer (70 μm, nylon, Falcon, USA). The filtrate related tissue microdamage, activation of satellite cells is was centrifuged for 20 min (350 g), which was repeated considered to play a crucial role in injured muscle fibers three times. After each centrifugation, supernatant was by incorporating new myonuclei and thus increasing discarded, cell pellet was re-suspended in growth muscle size and strength (by hypertrophy) [13]. medium (GM; 10%FBS/10% horse serum (HS) in MicroRNAs (miRNAs) are small non-coding interfering DMEM (Life Technologies, USA) and antibiotics (AB; RNA molecules (18–25 nucleotides) able to post- 0.5% amphotericin B (Fungizone, Life Technologies, transcriptionally regulate gene expression through USA), 1% penicillin-streptomycin (Life Technologies, sequence-specific base pairing to messenger ribonucleic USA)). After the last centrifugation, cell suspension was acid (mRNA). These molecules have been shown to be transferred to polystyrene Petri dishes (Becton Dickin- important key players in a variety of physiological and son, USA) for 1.5 h to allow adhesion of fibroblast. After pathological processes (proliferation, differentiation, apop- that, supernatant with satellite cells was transferred into tosis, hypertrophy, timing development, inflammation, culture dishes (Primaria Cell Culture Flask, Becton Dick- cancer, etc.). A group of miRNAs, highly enriched in skel- inson, USA) and cultured in GM. The growth medium etal and/or cardiac muscles (myomiRs), has recently been was changed every 2 days. On the tenth day of prolifera- identified and includes miR-1, miR-133a, miR-133b, miR- tion, cells were trypsinized, counted by Scepter Cell 206, miR-208, miR-208b, miR-486, and miR-499 [14] Counter (Merck Millipore, Germany), transferred which regulate skeletal muscle development. (30,000 cells from each isolation) to Collagen I Cellware Szcześniak et al. [15] were the first who demonstrated six-well plate (Greiner Bio-One, USA), and cultured in the effect of HMB in ESC. Our study was performed to GM. After reaching 80% confluency, the proliferation evaluate miRNA profile and relevant target genes in differ- media was replaced by the differentiation media (DM; entiating equine satellite cells incubated with HMB and 2%HS in DMEM with AB). Chodkowska et al. Genes & Nutrition (2018) 13:10 Page 3 of 20 Primary satellite cell cultures from semitendinosus MiRNA was isolated from eight equine satellite cell muscle of all horses were isolated, and the culture with cultures for both HMB pre-treated (n = 8) and control the best scores of cell viability (MTT assay) [16] and fu- group (n = 8). As recommended by Agilent Technologies sion
Recommended publications
  • E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Cell Review E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease Lan-Hsin Wang1 and Nicholas E. Baker1,2,3,* 1Department of Genetics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA 2Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA 3Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.devcel.2015.10.019 The basic Helix-Loop-Helix (bHLH) proteins represent a well-known class of transcriptional regulators. Many bHLH proteins act as heterodimers with members of a class of ubiquitous partners, the E proteins. A widely expressed class of inhibitory heterodimer partners—the Inhibitor of DNA-binding (ID) proteins—also exists. Genetic and molecular analyses in humans and in knockout mice implicate E proteins and ID proteins in a wide variety of diseases, belying the notion that they are non-specific partner proteins. Here, we explore relationships of E proteins and ID proteins to a variety of disease processes and highlight gaps in knowledge of disease mechanisms. E proteins and Inhibitor of DNA-binding (ID) proteins are widely conferring DNA-binding specificity and transcriptional activation expressed transcriptional regulators with very general functions. on heterodimers with the ubiquitous E proteins (Figure 1). They are implicated in diseases by evidence ranging from Another class of pervasive HLH proteins acts in opposition to confirmed Mendelian inheritance, association studies, and E proteins.
    [Show full text]
  • UBE2H Protein UBE2H Protein
    Catalogue # Aliquot Size U223-30H-20 20 µg U223-30H-50 50 µg UBE2H Protein Full length recombinant protein expressed in E. coli cells Catalog # U223-30H Lot # J581 -2 Product Description Purity Recombinant full length human UBE2H was expressed in E. coli cells using an N-terminal His tag. The gene accession number is NM_003344 . The purity of UBE2H was determined Gene Aliases to be >95% by densitometry. Approx. MW 21 kDa . E2-20K; UBC8; UBCH; UBCH2 Formulation Recombinant protein stored in 50mM sodium phosphate, pH 7.0, 300mM NaCl, 150mM imidazole, 0.1mM PMSF, 0.25mM DTT, 25% glycerol. Storage and Stability Store product at –70 oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles. Scientific Background UBE2H or ubiquitin-conjugating enzyme E2H is a member of the E2 ubiquitin-conjugating enzyme family which is located on chromosome 7 (1). UBE2H is known to act on histones and cytoskeletal proteins, both involved in the UBE2H Protein degenerative pathway of the motor neuron. UBE2H Full length recombinant protein expressed in E. coli cells expression is increased during erythroid differentiation of hCD34(+) cells. Tal1 transcription factor, which is essential Catalog Number U223-30H for the development of the hematopoietic system and Specific Lot Number J581-2 plays a role during definitive erythropoiesis in the adult, Purity >95% activates UBE2H expression, whereas Tal1 knock-down Concentration 0.1µg/ µl Stability 1yr At –70 oC from date of shipment reduced UBE2H expression and ubiquitin transfer activity Storage & Shipping Store product at –70 oC.
    [Show full text]
  • UBE2I Sirna Set I UBE2I Sirna Set I
    Catalog # Aliquot Size U224-911-05 3 x 5 nmol U224-911-20 3 x 20 nmol U224-911-50 3 x 50 nmol UBE2I siRNA Set I siRNA duplexes targeted against three exon regions Catalog # U224-911 Lot # Z2109-25 Specificity Formulation UBE2I siRNAs are designed to specifically knock-down The siRNAs are supplied as a lyophilized powder and human UBE2I expression. shipped at room temperature. Product Description Reconstitution Protocol UBE2I siRNA is a pool of three individual synthetic siRNA Briefly centrifuge the tubes (maximum RCF 4,000g) to duplexes designed to knock-down human UBE2I mRNA collect lyophilized siRNA at the bottom of the tube. expression. Each siRNA is 19-25 bases in length. The gene Resuspend the siRNA in 50 µl of DEPC-treated water accession number is NM_003345. (supplied by researcher), which results in a 1x stock solution (10 µM). Gently pipet the solution 3-5 times to mix Gene Aliases and avoid the introduction of bubbles. Optional: aliquot C358B7.1; P18; UBC9 1x stock solutions for storage. Storage and Stability Related Products The lyophilized powder is stable for at least 4 weeks at room temperature. It is recommended that the Product Name Catalog Number lyophilized and resuspended siRNAs are stored at or UBE2E3 (UBCH9) Protein U219-30H below -20oC. After resuspension, siRNA stock solutions ≥2 UBE2F Protein U220-30H µM can undergo up to 50 freeze-thaw cycles without UBE2G1 (UBC7) Protein U221-30H significant degradation. For long-term storage, it is UBE2H Protein U223-30H recommended that the siRNA is stored at -70oC. For most UBE2I Protein U224-30H favorable performance, avoid repeated handling and UBE2J1 Protein U225-30G multiple freeze/thaw cycles.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Fusion of the NH2-Terminal Domain of the Basic Helix-Loop-Helix Protein TCF12 to TEC in Extraskeletal Myxoid Chondrosarcoma with Translocation T(9;15)(Q22;Q21)1
    [CANCER RESEARCH 60, 6832–6835, December 15, 2000] Advances in Brief Fusion of the NH2-Terminal Domain of the Basic Helix-Loop-Helix Protein TCF12 to TEC in Extraskeletal Myxoid Chondrosarcoma with Translocation t(9;15)(q22;q21)1 Helene Sjo¨gren, Barbro Wedell, Jeanne M. Meis Kindblom, Lars-Gunnar Kindblom, and Go¨ran Stenman2 Lundberg Laboratory for Cancer Research, Department of Pathology, Go¨teborg University, SE-413 45 Go¨teborg, Sweden Abstract domain of TLS/FUS is linked to the entire coding region of the transcription factor CHOP as a result of a t(12;16)(q13;p11) (reviewed Extraskeletal myxoid chondrosarcomas (EMCs) are characterized by in Ref. 9). Thus, the NH -terminal transactivation domains of the recurrent t(9;22) or t(9;17) translocations resulting in fusions of the 2 EWS family of RNA binding proteins are regularly fusion partners of NH2-terminal transactivation domains of EWS or TAF2N to the entire TEC protein. We report here an EMC with a novel translocation t(9; various transcription factors in sarcomas, suggesting that they might 15)(q22;q21) and a third type of TEC-containing fusion gene. The chi- have important oncogenic properties. Indeed, it has been shown that meric transcript encodes a protein in which the first 108 amino acids of EWS-FLI1, TAF2N-FLI1, TLS-CHOP, and EWS-CHOP can trans- the NH2-terminus of the basic helix-loop-helix (bHLH) protein TCF12 is form 3T3 cells and that the transforming activity is dependent on linked to the entire TEC protein. The translocation separates the NH2- the presence of the NH2-terminal parts of EWS, TAF2N, and TLS terminal domain of TCF12 from the bHLH domain as well as from a (10–12).
    [Show full text]
  • Basic Helix-Loop-Helix Transcription Factor TCF21 Is a Downstream Target of the Male Sex Determining Gene SRY
    Basic Helix-Loop-Helix Transcription Factor TCF21 Is a Downstream Target of the Male Sex Determining Gene SRY Ramji K. Bhandari, Ingrid Sadler-Riggleman, Tracy M. Clement, Michael K. Skinner* Center for Reproductive Biology, School of Biological Sciences, Washington State University, Pullman, Washington, United States of America Abstract The cascade of molecular events involved in mammalian sex determination has been shown to involve the SRY gene, but specific downstream events have eluded researchers for decades. The current study identifies one of the first direct downstream targets of the male sex determining factor SRY as the basic-helix-loop-helix (bHLH) transcription factor TCF21. SRY was found to bind to the Tcf21 promoter and activate gene expression. Mutagenesis of SRY/SOX9 response elements in the Tcf21 promoter eliminated the actions of SRY. SRY was found to directly associate with the Tcf21 promoter SRY/SOX9 response elements in vivo during fetal rat testis development. TCF21 was found to promote an in vitro sex reversal of embryonic ovarian cells to induce precursor Sertoli cell differentiation. TCF21 and SRY had similar effects on the in vitro sex reversal gonadal cell transcriptomes. Therefore, SRY acts directly on the Tcf21 promoter to in part initiate a cascade of events associated with Sertoli cell differentiation and embryonic testis development. Citation: Bhandari RK, Sadler-Riggleman I, Clement TM, Skinner MK (2011) Basic Helix-Loop-Helix Transcription Factor TCF21 Is a Downstream Target of the Male Sex Determining Gene SRY. PLoS ONE 6(5): e19935. doi:10.1371/journal.pone.0019935 Editor: Ferenc Mueller, University of Birmingham, United Kingdom Received December 13, 2010; Accepted April 22, 2011; Published May 17, 2011 Copyright: ß 2011 Bhandari et al.
    [Show full text]
  • The MALDI TOF E2/E3 Ligase Assay As an Universal Tool for Drug Discovery in the Ubiquitin Pathway
    bioRxiv preprint doi: https://doi.org/10.1101/224600; this version posted November 29, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The MALDI TOF E2/E3 ligase assay as an universal tool for drug discovery in the ubiquitin pathway Virginia De Cesare*1, Clare Johnson2, Victoria Barlow2, James Hastie2 Axel Knebel1 and 5 Matthias Trost*1,3 1MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dow St, Dundee, DD1 5EH, Scotland, UK; 2MRC Protein Phosphorylation and Ubiquitylation Unit Reagents and Services, University of Dundee, Dow St, Dundee, DD1 5EH, Scotland, UK; . 3Institute for Cell and Molecular Biosciences, Newcastle University, Framlington Place, Newcastle-upon-Tyne, 10 NE2 1HH, UK *To whom correspondence should be addressed: Virginia De Cesare ([email protected]) Matthias Trost ([email protected]) 15 Contact information: V.D.C.: MRC PPU, University of Dundee, Dow St, Dundee, DD1 5EH, Phone: +44 1382 20 85822 M.T.: Newcastle University, Institute for Cell and Molecular Biosciences, Framlington Place, Newcastle-upon-Tyne, NE2 4HH, Phone: +44 191 2087009 Key words: Ubiquitin, E3 ligase, E2 enzyme, MALDI TOF, mass spectrometry, drug 25 discovery, high-throughput, assay, MDM2, HOIP, ITCH 1 bioRxiv preprint doi: https://doi.org/10.1101/224600; this version posted November 29, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • S41467-019-12388-Y.Pdf
    ARTICLE https://doi.org/10.1038/s41467-019-12388-y OPEN A tri-ionic anchor mechanism drives Ube2N-specific recruitment and K63-chain ubiquitination in TRIM ligases Leo Kiss1,4, Jingwei Zeng 1,4, Claire F. Dickson1,2, Donna L. Mallery1, Ji-Chun Yang 1, Stephen H. McLaughlin 1, Andreas Boland1,3, David Neuhaus1,5 & Leo C. James1,5* 1234567890():,; The cytosolic antibody receptor TRIM21 possesses unique ubiquitination activity that drives broad-spectrum anti-pathogen targeting and underpins the protein depletion technology Trim-Away. This activity is dependent on formation of self-anchored, K63-linked ubiquitin chains by the heterodimeric E2 enzyme Ube2N/Ube2V2. Here we reveal how TRIM21 facilitates ubiquitin transfer and differentiates this E2 from other closely related enzymes. A tri-ionic motif provides optimally distributed anchor points that allow TRIM21 to wrap an Ube2N~Ub complex around its RING domain, locking the closed conformation and promoting ubiquitin discharge. Mutation of these anchor points inhibits ubiquitination with Ube2N/ Ube2V2, viral neutralization and immune signalling. We show that the same mechanism is employed by the anti-HIV restriction factor TRIM5 and identify spatially conserved ionic anchor points in other Ube2N-recruiting RING E3s. The tri-ionic motif is exclusively required for Ube2N but not Ube2D1 activity and provides a generic E2-specific catalysis mechanism for RING E3s. 1 Medical Research Council Laboratory of Molecular Biology, Cambridge, UK. 2Present address: University of New South Wales, Sydney, NSW, Australia. 3Present address: Department of Molecular Biology, Science III, University of Geneva, Geneva, Switzerland. 4These authors contributed equally: Leo Kiss, Jingwei Zeng. 5These authors jointly supervised: David Neuhaus, Leo C.
    [Show full text]
  • Mutant P53 Drives Invasion in Breast Tumors Through Up-Regulation of Mir-155
    Oncogene (2013) 32, 2992–3000 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc ORIGINAL ARTICLE Mutant p53 drives invasion in breast tumors through up-regulation of miR-155 PM Neilsen1,2,5, JE Noll1,2,5, S Mattiske1,2,5, CP Bracken2,3, PA Gregory2,3, RB Schulz1,2, SP Lim1,2, R Kumar1,2, RJ Suetani1,2, GJ Goodall2,3,4 and DF Callen1,2 Loss of p53 function is a critical event during tumorigenesis, with half of all cancers harboring mutations within the TP53 gene. Such events frequently result in the expression of a mutated p53 protein with gain-of-function properties that drive invasion and metastasis. Here, we show that the expression of miR-155 was up-regulated by mutant p53 to drive invasion. The miR-155 host gene was directly repressed by p63, providing the molecular basis for mutant p53 to drive miR-155 expression. Significant overlap was observed between miR-155 targets and the molecular profile of mutant p53-expressing breast tumors in vivo. A search for cancer-related target genes of miR-155 revealed ZNF652, a novel zinc-finger transcriptional repressor. ZNF652 directly repressed key drivers of invasion and metastasis, such as TGFB1, TGFB2, TGFBR2, EGFR, SMAD2 and VIM. Furthermore, silencing of ZNF652 in epithelial cancer cell lines promoted invasion into matrigel. Importantly, loss of ZNF652 expression in primary breast tumors was significantly correlated with increased local invasion and defined a population of breast cancer patients with metastatic tumors. Collectively, these findings suggest that miR-155 targeted therapies may provide an attractive approach to treat mutant p53-expressing tumors.
    [Show full text]
  • De Novo Mutations in Inhibitors of Wnt, BMP, and Ras/ERK Signaling
    De novo mutations in inhibitors of Wnt, BMP, and PNAS PLUS Ras/ERK signaling pathways in non-syndromic midline craniosynostosis Andrew T. Timberlakea,b, Charuta G. Fureya,c,1, Jungmin Choia,1, Carol Nelson-Williamsa,1, Yale Center for Genome Analysis2, Erin Loringa, Amy Galmd, Kristopher T. Kahlec, Derek M. Steinbacherb, Dawid Larysze, John A. Persingb, and Richard P. Liftona,f,3 aDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06510; bSection of Plastic and Reconstructive Surgery, Yale University School of Medicine, New Haven, CT 06510; cDepartment of Neurosurgery, Yale University School of Medicine, New Haven, CT 06510; dCraniosynostosis and Positional Plagiocephaly Support, New York, NY 10010; eDepartment of Radiotherapy, The Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, 44-101 Gliwice, Poland; and fLaboratory of Human Genetics and Genomics, The Rockefeller University, New York, NY 10065 Contributed by Richard P. Lifton, July 13, 2017 (sent for review June 6, 2017; reviewed by Yuji Mishina and Jay Shendure) Non-syndromic craniosynostosis (NSC) is a frequent congenital ing pathways being implicated at lower frequency (5). Examples malformation in which one or more cranial sutures fuse pre- include gain-of-function (GOF) mutations in FGF receptors 1–3, maturely. Mutations causing rare syndromic craniosynostoses in which present with craniosynostosis of any or all sutures with humans and engineered mouse models commonly increase signaling variable hypertelorism, proptosis, midface abnormalities, and of the Wnt, bone morphogenetic protein (BMP), or Ras/ERK path- syndactyly, and loss-of-function (LOF) mutations in TGFBR1/2 ways, converging on shared nuclear targets that promote bone that present with craniosynostosis in conjunction with severe formation.
    [Show full text]
  • Mechanism of Ssph1: a Bacterial Effector Ubiquitin Ligase
    © Copyright 2018 Matthew J. Cook Mechanism of SspH1: A Bacterial Effector Ubiquitin Ligase Hijacks the Eukaryotic Ubiquitylation Pathway Matthew J. Cook A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2018 Reading Committee: Peter S Brzovic, Chair Suzanne Hoppins Ning Zheng Program Authorized to Offer Degree: Biochemistry University of Washington Abstract Mechanism of SspH1: A Bacterial Effector Ubiquitin Ligase Hijacks the Eukaryotic Ubiquitylation Pathway Matthew J. Cook Chair of the Supervisory Committee: Peter S Brzovic Department of Biochemistry Bacterial effector proteins promote the pathogenicity of bacteria by interacting with host cell proteins and modulating signaling pathways in the host cell. Some bacterial effectors hijack the eukaryotic ubiquitylation pathway to promote pathogenicity, despite the absence of the pathway in prokaryotes. One family of bacterial effectors, the IpaH-SspH family of E3 ligases, are unrelated in sequence or structure to eukaryotic E3s. This work elucidates key aspects in the structure and mechanism of one member of the IpaH-SspH family from Salmonella typhimurium, SspH1. Biophysical and biochemical methods were used to examine the structure of SspH1 in solution and the interactions between SspH1 and components of the eukaryotic ubiquitylation pathway, with an emphasis on the mechanisms of ubiquitin transfer from the E2 active site to the SspH1 active site, and from the SspH1 active site to substrate. Important results of this work include 1) a reanalysis of existing crystal structures of IpaH-SspH1 E3 domains leading to a new way of characterizing the structural organization of the SspH1 E3 domain, revealing two independent subdomains.
    [Show full text]
  • HRD1 and UBE2J1 Target Misfolded MHC Class I Heavy Chains for Endoplasmic Reticulum- Associated Degradation
    HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum- associated degradation Marian L. Burr, Florencia Cano, Stanislava Svobodova, Louise H. Boyle, Jessica M. Boname, and Paul J. Lehner1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom Edited* by Peter Cresswell, Yale University School of Medicine, New Haven, CT, and approved December 21, 2010 (received for review October 29, 2010) The assembly of MHC class I molecules is governed by stringent orthologs of yeast Hrd1p, HRD1 (Synoviolin) and gp78 (AMFR), endoplasmic reticulum (ER) quality control mechanisms. MHC class I have distinct substrate specificities, exemplifying the increased heavy chains that fail to achieve their native conformation in complexity of mammalian ERAD (6, 7). HRD1 is implicated in the complex with β2-microglobulin (β2m) and peptide are targeted for pathogenesis of rheumatoid arthritis (10), and reported substrates ER-associated degradation. This requires ubiquitination of the MHC include α1-antitrypsin variants (11) and amyloid precursor protein class I heavy chain and its dislocation from the ER to the cytosol for (12). Three E2 ubiquitin-conjugating enzymes function in mam- proteasome-mediated degradation, although the cellular machin- malian ERAD: UBE2J1 and UBE2J2 (yeast Ubc6p orthologs) and ery involved in this process is unknown. Using an siRNA functional UBE2G2 (yeast Ubc7p ortholog) (7, 8, 13). screen in β2m-depleted cells, we identify an essential role for the E3 Many viruses down-regulate cell-surface MHC I to evade im- ligase HRD1 (Synoviolin) together with the E2 ubiquitin-conjugating mune detection (2). The human cytomegalovirus US2 and US11 gene products bind newly synthesized MHC I HCs and initiate enzyme UBE2J1 in the ubiquitination and dislocation of misfolded their rapid dislocation to the cytosol for proteasomal degradation MHC class I heavy chains.
    [Show full text]